Skip to main content

Table 4 Overall survival of the studied AML patients

From: Interleukin-4 gene intron 3 VNTR polymorphism in adult acute myeloid leukemia

Groups Total N N of events OS (months) 95% CI Survival at (%) months Log Rank Test
Median SE Lower Upper 3 months (%) 6 months (%) 12 months (%) X2 P value
P1P1 and P1P2 26 14 3 0.573 1.876 4.124 61.50 44.40 44.40 0.399 0.527
P2P2 24 12 12 4.088 3.987 20.013 66.70 57.10 38.10
  1. OS overall survival, SE standard error, N number